title: The Prevalence of Hypoglycemia and Its Impact on The Quality of Life of Type 2 Diabetes Mellitus Patients in Greece (The Hypo Study).
authors.affiliation: National and Kapodistrian University of Athens, Athens, Greece.
authors.forename: J
authors.initials: J
authors.lastname: Yfantopoulos
authors.affiliation: Novartis Hellas, Metamorfosis, Greece.
authors.forename: M
authors.initials: M
authors.lastname: Hatzikou
authors.affiliation: Novartis Hellas, Metamorfosis, Greece.
authors.forename: G
authors.initials: G
authors.lastname: Rombopoulos
authors.affiliation: Novartis Hellas, Metamorfosis, Greece.
authors.forename: E
authors.initials: E
authors.lastname: Panitti
authors.affiliation: University of Peloponnese, Corinth, Greece Hypoglycemia (Hypo) is a common adverse effect of type 2 diabetes (T2D) therapy. Hypo has a negative impact on health care resources and quality of life (QoL) and can affect compliance and T2D control.
authors.forename: D
authors.initials: D
authors.lastname: Latsou